Glucagon and Omniscan drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Glucagon (glucagon hydrochloride) and Omniscan (gadodiamide). Common drug interactions include muscular weakness among females and nephrogenic systemic fibrosis among males.

The phase IV clinical study analyzes what interactions people have when they take Glucagon and Omniscan. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Glucagon?

Glucagon has active ingredients of glucagon hydrochloride. eHealthMe is studying from 4,297 Glucagon users. Check the latest studies of Glucagon.

What is Omniscan?

Omniscan has active ingredients of gadodiamide. eHealthMe is studying from 6,169 Omniscan users. Check the latest studies of Omniscan.

On Jul, 17, 2026

16 people who take Glucagon and Omniscan together, and have interactions are studied.

Glucagon and Omniscan drug interactions.

What are the common drug interactions of Glucagon and Omniscan, by gender? *:

female:

Muscular weakness (muscle weakness)
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Arthralgia (joint pain)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Back pain
Depression
Hypertonia (abnormal increase in muscle tension and a reduced ability of a muscle to stretch)
Joint range of motion decreased (disease of joint movement)
Mitral valve replacement

male:

Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
Anxiety
Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
Pain
Scar
Skin induration (an abnormally hard spot or area on the skin)
Skin fibrosis (fibrous tissue formation on skin)
Chest pain
Fatigue (feeling of tiredness)
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)

What are the common drug interactions of Glucagon and Omniscan, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Anxiety
Asthenia (weakness)
Emotional distress
Extremity contracture (permanent shortening of a muscle or joint of arms and legs)
Fibrosis (formation of excess fibrous connective tissue in an organ or tissue)
Gait disturbance
General physical health deterioration (weak health status)
Joint contracture (a permanent shortening of a muscle or joint)
Mobility decreased (ability to move is reduced)
Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)

50-59:

Anxiety
Arthralgia (joint pain)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Back pain
Depression
Hypertonia (abnormal increase in muscle tension and a reduced ability of a muscle to stretch)
Joint range of motion decreased (disease of joint movement)
Mitral valve replacement
Muscular weakness (muscle weakness)
Pain in extremity

60+:

Chills (felling of cold)
Dizziness
Malaise (a feeling of general discomfort or uneasiness)
Muscular weakness (muscle weakness)
Nausea (feeling of having an urge to vomit)
Vomiting
Nephrogenic fibrosing dermopathy (involves fibrosis of skin, joints, eyes due to kidney disease)
Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)

What are the existing conditions these people have? *

Pain: 7 people, 43.75%
Hypoglycemia (low blood sugar): 6 people, 37.50%
Neoplasm Malignant (cancer tumour): 5 people, 31.25%
Immunodeficiency: 5 people, 31.25%
Stable Angina (a constant chest pain): 5 people, 31.25%
Diabetes: 5 people, 31.25%
High Blood Pressure: 5 people, 31.25%
Immunodeficiency Disorders: 5 people, 31.25%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 5 people, 31.25%
Blood Triglycerides Decreased: 3 people, 18.75%

* Approximation only. Some reports may have incomplete information.

Do you take Glucagon and Omniscan?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously